Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Schwartzkopff

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Medizinische Klinik|September 17, 1976
[The effect of etiroxate on serum lipids after myocardial infarction or in angina pectoris]W Schwartzkopff, H Hoffmann, J Nijssen, et al.
Der Anaesthesist|June 1, 1977
[Haemodynamic effects of dextran 6% in the treatment of haemorrhage (author's transl)]W Strey, W Schwartzkopff, W Wurm, et al.
Zeitschrift Fur Hautkrankheiten|September 1, 1982
[Changes in serum lipid fractions as a side effect of oral retinoids]H Gollnick, C Luley, W Schwartzkopff, et al.
Artery|January 1, 1980
The effect of etofibrate retard, bezafibrate and procetofenC Luley, W Schwartzkopff, A Schilling, et al.
Arzneimittel-Forschung|April 1, 1986
Lack of efficacy of dried garlic in patients with hyperlipoproteinemiaC Luley, W Lehmann-Leo, B Möller, et al.
Biomedizinische Technik. Biomedical Engineering|October 1, 1989
[Kinetics of lipids and lipoproteins with determination of the recovery rate in the non-steady state following plasma, membrane filtration and dextran sulfate adsorption apheresis in hypercholesterolemia]W Schwartzkopff, H Gräfenhahn, A Nold, et al.
Atherosclerosis|January 1, 1983
Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patientsS Blümcke, W Schwartzkopff, H Lobeck, et al.
Atherosclerosis|June 1, 1990
Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarctionW Schwartzkopff, J Schleicher, I Pottins, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1981
[The detection of apolipoproteins AI and B in the liver of patients with and without hyperlipoproteinemia (author's transl)]U Hopf, W Schwartzkopff, G Assmann, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Medizinische Klinik|September 17, 1976
[The effect of etiroxate on serum lipids after myocardial infarction or in angina pectoris]W Schwartzkopff, H Hoffmann, J Nijssen, et al.
Der Anaesthesist|June 1, 1977
[Haemodynamic effects of dextran 6% in the treatment of haemorrhage (author's transl)]W Strey, W Schwartzkopff, W Wurm, et al.
Zeitschrift Fur Hautkrankheiten|September 1, 1982
[Changes in serum lipid fractions as a side effect of oral retinoids]H Gollnick, C Luley, W Schwartzkopff, et al.
Artery|January 1, 1980
The effect of etofibrate retard, bezafibrate and procetofenC Luley, W Schwartzkopff, A Schilling, et al.
Arzneimittel-Forschung|April 1, 1986
Lack of efficacy of dried garlic in patients with hyperlipoproteinemiaC Luley, W Lehmann-Leo, B Möller, et al.
Biomedizinische Technik. Biomedical Engineering|October 1, 1989
[Kinetics of lipids and lipoproteins with determination of the recovery rate in the non-steady state following plasma, membrane filtration and dextran sulfate adsorption apheresis in hypercholesterolemia]W Schwartzkopff, H Gräfenhahn, A Nold, et al.
Atherosclerosis|January 1, 1983
Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patientsS Blümcke, W Schwartzkopff, H Lobeck, et al.
Atherosclerosis|June 1, 1990
Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men and women with and without myocardial infarctionW Schwartzkopff, J Schleicher, I Pottins, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1981
[The detection of apolipoproteins AI and B in the liver of patients with and without hyperlipoproteinemia (author's transl)]U Hopf, W Schwartzkopff, G Assmann, et al.
Pageof 2